Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $6.27 Million - $6.98 Million
-30,000 Reduced 60.0%
20,000 $4.37 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $9.88 Million - $11.4 Million
50,000 New
50,000 $11.4 Million
Q1 2023

May 09, 2023

BUY
$213.32 - $257.83 $4.27 Million - $5.16 Million
20,000 New
20,000 $4.59 Million
Q1 2022

May 12, 2022

SELL
$259.82 - $298.18 $5.2 Million - $5.96 Million
-20,000 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$271.6 - $314.21 $5.43 Million - $6.28 Million
20,000 New
20,000 $6.28 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $6.3 Million - $6.95 Million
-25,000 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$204.88 - $255.03 $5.12 Million - $6.38 Million
25,000 New
25,000 $6.38 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.